Abstract
Biotechnology is a topic of considerable diversity and implications for the future, if not the very philosophy, of health care. In many respects, biotechnology differs markedly from traditional sources of new therapeutic agents. Biotechnology is viewed as encompassing three major areas: genetic engineering, molecular synthesis, and drug delivery systems. Each of these a as is an important source of pharmacologic agents. The implications for biotechnology for the drug development process are examined with particular reference to opportunities for the statistician or bio-statistician to contribute.
| Original language | English |
|---|---|
| Pages (from-to) | 499-513 |
| Number of pages | 15 |
| Journal | Drug Information Journal |
| Volume | 22 |
| Issue number | 4 |
| DOIs | |
| State | Published - Oct 1988 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Scopus Subject Areas
- Pharmacology (nursing)
- Drug guides
- Public Health, Environmental and Occupational Health
- Pharmacology (medical)
Keywords
- Biostatistics
- Biotechnology
- Drug development
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver